Model-Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs

标题
Model-Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 48, Issue 12, Pages 1420-1429
出版商
Wiley
发表日期
2008-10-21
DOI
10.1177/0091270008323260

向作者/读者发起求助以获取更多资源

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started